6.07
                                            
                                Überblick
                                Nachrichten
                                Preisverlauf
                                    Optionskette
                                Financials
                                    Warum fällt CAPR?
                                Forum
                                Prognose
                                    Aktiensplit
                        
                        Capricor Therapeutics Inc Aktie (CAPR) Neueste Nachrichten
Why Capricor Therapeutics Inc. stock is a must watch in 2025July 2025 Patterns & Fast Entry High Yield Tips - newser.com
How high can Capricor Therapeutics Inc. stock go2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback - Stocktwits
Chart based analysis of Capricor Therapeutics Inc. trends2025 Support & Resistance & Verified Short-Term Trading Plans - newser.com
What valuation multiples suggest for Capricor Therapeutics Inc. stockPortfolio Update Report & Growth Oriented Trade Recommendations - newser.com
Capricor Therapeutics (CAPR) Advances DMD Treatment with New Res - GuruFocus
Strategies to average down on Capricor Therapeutics Inc.2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
What insider purchases suggest about Capricor Therapeutics Inc. (4LN2) stockJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
Capricor (NASDAQ: CAPR) publishes Deramiocel MOA; assay supports Phase 3 DMD - Stock Titan
Smart tools for monitoring Capricor Therapeutics Inc.’s price actionJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
Is Capricor Therapeutics Inc. (4LN2) stock a momentum leader2025 Earnings Surprises & Low Risk Entry Point Guides - newser.com
Will Capricor Therapeutics Inc. price bounce be sustainableQuarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Will Capricor Therapeutics Inc. (4LN2) stock outperform energy sector in 2025July 2025 Earnings & Trade Opportunity Analysis - newser.com
Price momentum metrics for Capricor Therapeutics Inc. explained2025 Trading Volume Trends & Long-Term Growth Stock Strategies - newser.com
What institutional flow reveals about Capricor Therapeutics Inc.July 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Will Capricor Therapeutics Inc. stock benefit from upcoming earnings reportsMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Capricor Therapeutics Inc.’s volatility index tracking explainedGap Up & Daily Growth Stock Tips - newser.com
Chart overlay techniques for tracking Capricor Therapeutics Inc.Weekly Trend Summary & Community Supported Trade Ideas - newser.com
Will Capricor Therapeutics Inc. (4LN2) stock see insider accumulationGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Capricor Therapeutics, Inc. (CAPR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is it too late to sell Capricor Therapeutics Inc.Market Movers & Community Driven Trade Alerts - newser.com
HBK Sorce Advisory LLC Increases Stake in Capricor Therapeutics, Inc. $CAPR - MarketBeat
Capricor Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10 - The Manila Times
Capricor Therapeutics to Announce Third Quarter 2025 Financial Results on November 10, 2025 - Quiver Quantitative
We're Hopeful That Capricor Therapeutics (NASDAQ:CAPR) Will Use Its Cash Wisely - Yahoo Finance
What technical charts say about Capricor Therapeutics Inc. stockEarnings Growth Summary & AI Driven Stock Movement Reports - newser.com
How big funds are accumulating Capricor Therapeutics Inc. (4LN2) stockPortfolio Performance Report & Free Fast Gain Swing Trade Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Capricor Therapeutics, Inc. (CAPR) And Encourages Investors to Reach Out - ACCESS Newswire
Capricor (CAPR) Moves 12.0% Higher: Will This Strength Last? - Nasdaq
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):